Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)
31.74
+0.95 (3.09%)
At close: Apr 1, 2026
SHA:688161 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 273.8 | 223.75 | 112.32 | 600.7 | 690.32 |
Depreciation & Amortization | 66.96 | 57.85 | 62.4 | 56.91 | 51.48 |
Other Amortization | 48.21 | 52.99 | 43.49 | 42.02 | 42.34 |
Loss (Gain) From Sale of Assets | -0.15 | -6.37 | -0.02 | -0.27 | -0.03 |
Asset Writedown & Restructuring Costs | 31.12 | 0.25 | 0.2 | 0.04 | 3.81 |
Loss (Gain) From Sale of Investments | -30.92 | -27.32 | -27.69 | -27.57 | -22.78 |
Provision & Write-off of Bad Debts | - | -8.29 | -5.29 | 15.02 | 10.13 |
Other Operating Activities | 9.13 | 45.51 | 21.08 | 1.62 | 1.35 |
Change in Accounts Receivable | -65.35 | 34.14 | 227.83 | -105.88 | -102.56 |
Change in Inventory | 16.58 | 13.11 | -160.54 | -143.72 | -49.72 |
Change in Accounts Payable | 37.57 | -111.36 | -137.02 | 69.28 | 169.3 |
Change in Other Net Operating Assets | 27.92 | - | - | - | - |
Operating Cash Flow | 415.42 | 274.19 | 119.44 | 508.56 | 788.25 |
Operating Cash Flow Growth | 51.51% | 129.56% | -76.51% | -35.48% | 22.38% |
Capital Expenditures | -27.09 | -24.34 | -42.98 | -115.76 | -112.41 |
Sale of Property, Plant & Equipment | 14.65 | 0.57 | 2.08 | 1.41 | 0.21 |
Cash Acquisitions | - | - | -43.22 | - | - |
Investment in Securities | -638.5 | -203 | -20 | -90 | -1,090 |
Other Investing Activities | 32.76 | 33.15 | 10.46 | 48.71 | 12.06 |
Investing Cash Flow | -618.18 | -193.62 | -81.57 | -129.46 | -1,188 |
Long-Term Debt Issued | - | 8.54 | - | - | - |
Long-Term Debt Repaid | - | -5.71 | -4.83 | -4.85 | -4.45 |
Net Debt Issued (Repaid) | - | 2.83 | -4.83 | -4.85 | -4.45 |
Issuance of Common Stock | - | - | - | - | 1,405 |
Repurchase of Common Stock | - | -35 | -45.01 | - | - |
Common Dividends Paid | -127.69 | -75.25 | -163.99 | -211.44 | - |
Other Financing Activities | -112.31 | -103 | -710.54 | -12.39 | -46.58 |
Financing Cash Flow | -239.99 | -210.43 | -924.36 | -228.68 | 1,354 |
Foreign Exchange Rate Adjustments | -0.87 | 0.92 | 0.18 | -0.55 | -0.09 |
Net Cash Flow | -443.63 | -128.93 | -886.31 | 149.88 | 953.8 |
Free Cash Flow | 388.33 | 249.85 | 76.46 | 392.8 | 675.84 |
Free Cash Flow Growth | 55.42% | 226.76% | -80.53% | -41.88% | 13.68% |
Free Cash Flow Margin | 25.50% | 17.20% | 5.96% | 19.09% | 31.38% |
Free Cash Flow Per Share | 0.97 | 0.63 | 0.19 | 0.98 | 1.78 |
Cash Interest Paid | - | 0.23 | 0.21 | 0.54 | - |
Cash Income Tax Paid | 204.04 | 162.21 | 233.32 | 328.76 | 368.51 |
Levered Free Cash Flow | -1,309 | 125.96 | 452.76 | 230.39 | 488.41 |
Unlevered Free Cash Flow | -1,309 | 126.61 | 453.36 | 230.78 | 488.79 |
Change in Working Capital | 17.27 | -64.17 | -87.05 | -179.91 | 11.63 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.